Document:

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

	Warrant
    No. __________	 	Number
    of Shares: ______
	Date
    of Issuance:   December __, 2017	 	(subject
    to adjustment)

 

SURNA
INC.

 

Common
Stock Warrant

 

Surna
Inc., a Nevada corporation (the “Company”), for value received, hereby certifies that ____________________, or its
registered assigns (the “Registered Holder”), is entitled, subject to the terms set forth below, to purchase from
the Company at any time after the Date of Issuance and on or before December ___, 2020 (the “Expiration Date”), _______
shares (as adjusted from time to time pursuant to the provisions of this Warrant) of common stock, par value $0.00001 per share,
of the Company (the “Common Stock”), at an exercise price of $0.20 per share. The shares issuable upon exercise of
this Warrant and the exercise price per share, as adjusted from time to time pursuant to the provisions of this Warrant, are sometimes
hereinafter referred to as the “Warrant Shares” and the “Exercise Price,” respectively.

 

This
Warrant is issued pursuant to that certain Securities Purchase Agreement dated as of December 12, 2017 by and among the Company
and the purchasers signatory thereto (the “Purchase Agreement”). Capitalized terms used and not otherwise defined
herein shall have the meanings set forth in the Purchase Agreement.

 

		1.	Exercise

 

a. Exercise
By Registered Holder. At any time on or after the Date of Issuance and on or before the Expiration Date, this Warrant
may be exercised by the Registered Holder, in whole or in part, by surrendering this Warrant, with the purchase/exercise form
attached hereto as Exhibit A (the “Notice of Exercise”) duly executed by the Registered Holder or by the
Registered Holder’s duly authorized attorney, at the principal office of the Company, or at such other office or agency
as the Company may designate, accompanied by payment in full of the aggregate Exercise Price payable in respect of the number
of Warrant Shares purchased upon such exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything
herein to the contrary, the Registered Holder shall not be required to physically surrender this Warrant to the Company until
the Registered Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Registered Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in
purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the
outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares
purchased. The Registered Holder and the Company shall maintain records showing the number of Warrant Shares purchased and
the date of such purchases, provided, however, if there are any discrepancies, the records of the Company shall prevail. The
Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The
Registered Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of
this Section 1(a), following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares
available for purchase hereunder at any given time may be less than the amount stated on the face hereof. The Exercise Price
may be paid by certified check or wire transfer.

 

    	 

     

    

 

b. Call
(Redemption) Provisions. Notwithstanding anything to the contrary contained in this Warrant, this Warrant is callable
(redeemable) at the Company’s option at any time, provided the closing price of the Common Stock is $0.36 (adjusted to
reflect forward or reverse stock splits, recapitalizations, reorganizations or the like) or greater for five (5) consecutive
Trading Days on the Trading Market (the “Call Condition”). Commencing at any time after the date on which the
Call Condition is satisfied, the Company shall have the right, upon notice to the Registered Holder (the “Redemption
Notice”), to redeem the number of Warrant Shares specified in the applicable Call Condition at a price of $0.01 per
Warrant Share (the “Redemption Price”), on the date set forth in the Redemption Notice, but in no event earlier
than sixty-one (61) days following the date of the receipt by the Registered Holder of the Redemption Notice (the
“Redemption Date”). The Registered Holder may exercise this Warrant at any time (in whole or in part) prior to
the Redemption Date at the Exercise Price. Any portion of this Warrant that is subject to the applicable Call Condition which
is not exercised by the Redemption Date shall no longer be exercisable and shall be returned to the Company (and, if not so
returned, shall automatically be deemed canceled), and the Company, upon its receipt of the unexercised portion of this
Warrant, shall issue therefore in full and complete satisfaction of its obligations under such called but unexercised portion
of this Warrant to the Registered Holder an amount equal to the number of shares of Common Stock called but remaining
unexercised multiplied by the Redemption Price. The Redemption Price shall be mailed to such Registered Holder at its address
of record, and the Warrant shall be canceled.

 

c. Mechanics
of Exercise.

 

i. Delivery
of Warrant Shares upon Exercise. Warrant Shares purchased hereunder shall be transmitted by the Company or its transfer
agent to the Registered Holder in the Notice of Exercise within a commercially reasonable time, pursuant to SEC regulations,
with the goal of accomplishing such action within three (3) Trading Days after delivery to the Company of the Notice of
Exercise (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued,
and the Registered Holder or any other person so designated to be named therein shall be deemed to have become a holder of
record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the
Exercise Price and all taxes required to be paid by the Registered Holder, if any, having been paid and collected.

 

ii. Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
the Registered Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver
to the Registered Holder a new Warrant evidencing the rights of the Registered Holder to purchase the unpurchased Warrant
Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the
exercise of this Warrant. As to any fraction of a share which the Registered Holder would otherwise be entitled to purchase
upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an
amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

iv. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Registered Holder for any issue or
transfer tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall
be paid by the Company, and such Warrant Shares shall be issued in the name of the Registered Holder or in such name or names
as may be directed by the Registered Holder; provided, however, that in the event that Warrant Shares are to be issued in a
name other than the name of the Registered Holder, this Warrant when surrendered for exercise shall be accompanied by the
Assignment Form attached hereto duly executed by the Registered Holder and the Company may require, as a condition thereto,
the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all transfer
agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or
another established clearing corporation performing similar functions) required for same-day electronic delivery of the
Warrant Shares as applicable.

 

    	 	2	 

     

    

 

v.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely
exercise of this Warrant, pursuant to the terms hereof.

 

		2.	Adjustments.

 

a.
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 2(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re
classification.

 

b. Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions for which shareholder approval is required, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or
more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares
of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other
Persons making or party to, such stock or share purchase agreement or other business combination) (each a
“Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Registered Holder shall have
the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
occurrence of such Fundamental Transaction, at the option of the Registered Holder, the number of shares of Common Stock of
the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder
of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental
Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a
Fundamental Transaction, then the Registered Holder shall be given the same choice as to the Alternate Consideration it
receives upon any exercise of this Warrant following such Fundamental Transaction.

 

    	 	3	 

     

    

 

c. Calculations. All
calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and
outstanding.

 

d. Notice
to Registered Holder.

 

i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 2, the Company
shall promptly mail to the Registered Holder a notice setting forth the Exercise Price after such adjustment and any
resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such
adjustment.

 

ii. Notice
to Allow Exercise by Registered Holder. If (A) the Company shall declare a dividend (or any other distribution in
whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of
the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to
subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of
the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to
which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any
compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company
shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in
each case, the Company shall cause to be mailed to the Registered Holder at its last address as it shall appear upon the
Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of
record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or
close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their
shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the
mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent
that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company, the
Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K, provided that the
requirement in this sentence shall only apply if any of the Company’s securities are listed or quoted for
public trading. The Registered Holder shall remain entitled to exercise this Warrant during the period commencing on the date
of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth
herein

 

		3.	Transfers.

 

a.
Unregistered Security. Each Registered Holder acknowledges that this Warrant and the Warrant Shares have not been registered
under the Securities Act of 1933, as amended (the “Securities Act”), and agrees not to sell, pledge, distribute, offer
for sale, transfer, or otherwise dispose of this Warrant or any Warrant Shares issued upon its exercise in the absence of (i)
an effective registration statement under the Securities Act as to this Warrant or such Warrant Shares and registration or qualification
of this Warrant or such Warrant Shares under any applicable U.S. federal or state securities law then in effect or (ii) at the
cost of the Registered Holder of this Warrant, an opinion of counsel, satisfactory to the Company, that such registration and
qualification are not required. The Registered Holder acknowledges that the Warrant Shares acquired upon the exercise of this
Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws. It is estimated that
there will be at least a six month minimum holding period before any resales may be made of the Warrant Shares in the public market,
however depending on the circumstances from time to time. Each certificate or other instrument for Warrant Shares issued upon
the exercise of this Warrant shall bear a legend substantially to the foregoing effect.

 

b. Transferability.
Subject to the provisions of Section 3(a) hereof, this Warrant and all rights hereunder are transferable, in whole or in
part, upon surrender of this Warrant with a properly executed assignment (in the form of Exhibit B hereto) at the
principal office of the Company.

 

    	 	4	 

     

    

 

c. Warrant
Register. The Company will maintain a register containing the names and addresses of the Registered Holders of this
Warrant. Until any transfer of this Warrant is made in the warrant register, the Company may treat the Registered Holder of
this Warrant as the absolute owner hereof for all purposes; provided, however, that if this Warrant is properly
assigned in blank, the Company may (but shall not be required to) treat the bearer hereof as the absolute owner hereof for
all purposes, notwithstanding any notice to the contrary. Any Registered Holder may change such Registered Holder’s
address as shown on the warrant register by written notice to the Company requesting such change.

 

d. Legend
of Warrant Shares. The Registered Holder agrees that the Warrant Shares upon issuance may be notated with the following
legend or legend of similar import: “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN
OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF
1933, AS AMENDED.” The Registered Holder agrees that in conformity with the Securities Purchase Agreement any other
relevant legends may be affixed to the certificates or notations representing the Warrant Shares as applicable
thereto.

 

4.
No Impairment. The Company will not, by amendment of its charter or through reorganization, consolidation, merger, dissolution,
sale of assets, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action
as may be necessary or appropriate in order to protect the rights of the Registered Holder against impairment.

 

5. Termination.
This Warrant (and the right to purchase securities upon exercise hereof) shall terminate on the Expiration Date.

 

6. Reservation
of Stock. The Company will reserve and use reasonable commercial efforts to keep available, solely for the issuance and
delivery upon the exercise of this Warrant, the Warrant Shares and other stock, securities, and property, as from time to
time shall be issuable upon the exercise of this Warrant

 

7. Exchange
of Warrants. Upon the surrender by the Registered Holder of this Warrant, properly endorsed, to the Company at the
principal office of the Company, the Company will, subject to the provisions of Section 3 hereof, issue and deliver to or
upon the order of such Registered Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the
name of such Registered Holder or as such Registered Holder (upon payment by such Registered Holder of any applicable
transfer taxes) may direct, calling in the aggregate on the face or faces thereof for the number of Warrant Shares called for
on the face or faces of the Warrant or Warrants so surrendered.

 

8. Replacement
of Warrants. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or
mutilation of this Warrant and (in the case of loss, theft, or destruction) upon delivery of an indemnity agreement (with
surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor.

 

9. Miscellaneous.

 

a. No
Rights as Stockholder. Until the exercise of this Warrant, the Registered Holder of this Warrant shall not have or
exercise any rights by virtue hereof as a stockholder of the Company.

 

b. Amendment
or Waiver. Any term of this Warrant may be amended or waived upon written consent of the Company and the
Registered Holder.

 

    	 	5	 

     

    

 

c. Headings.
The headings in this Warrant are used for convenience only and are not to be considered in construing or interpreting any
provision of this Warrant.

 

d. Governing
Law. This Warrant shall be governed, construed, and interpreted in accordance with the laws of the state of Colorado,
without giving effect to principles of conflicts of law.

 

e. Successors
and Assigns. Unless otherwise provided in this Warrant, the terms and conditions of this Warrant shall inure to the
benefit of and be binding upon the permitted successors and assigns of the parties. Nothing in this Warrant, express or
implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any
rights, remedies, obligations, or liabilities under or by reason of this Warrant, except as expressly provided in this
Warrant.

 

f. Severability.
If one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision shall be
excluded from this Warrant, the balance of this Warrant shall be interpreted as if such provision were so excluded and shall
be enforceable in accordance with its terms.

 

g. Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Warrant,
upon any breach or default of any other party under this Warrant, shall impair any such right, power, or remedy of such
non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single
breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit,
consent, or approval of any kind or character on the part of any party of any breach or default under this Warrant, or any
waiver on the part of any party of any provisions or conditions of this Warrant, must be in writing and shall be effective
only to the extent specifically set forth in such writing. All remedies, either under this Warrant or by law or otherwise
afforded to any party, shall be cumulative and not alternative. If the Company willfully and knowingly fails to comply with
any provision of this Warrant, which results in any material damages to the Registered Holder, the Company shall pay to the
Registered Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to,
reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Registered Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h. Notices.
All notices, requests, consents, demands, and other communications hereunder shall be in writing and shall be deemed to have
been duly given on the date of service if served personally on the party to whom notice is to be given, on the date of
transmittal of services via telecopy or email to the party to whom notice is to be given (with a confirming copy delivered
within 24 hours thereafter), or on the third day after mailing if mailed to the party to whom notice is to be given, by first
class mail, registered or certified, postage prepaid, or on the next day after mailing if overnight mail via a nationally
recognized courier providing a receipt for delivery and properly addressed at the respective addresses of the parties as set
forth herein. Any party may change its address for purposes of this paragraph by giving notice of the new address to each of
the other parties in the manner set forth above.

 

i. Representation
by Registered Holder. The Registered Holder, by the acceptance hereof, represents and warrants that it is acquiring this
Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and
not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities
Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities
Act.

 

j. Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the
next succeeding Business Day.

 

    	 	6	 

     

    

 

k. Authorized
Shares. The Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute
full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such
Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be traded. The Company covenants that all Warrant Shares which may be
issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

l. Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Registered Holder to exercise this
Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Registered Holder, shall
give rise to any liability of the Registered Holder for the Exercise Price of any Warrant Shares or as a stockholder of the
Company, whether such liability is asserted by the Company or by creditors of the Company.

 

m. Remedies. The
Registered Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be
adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be
adequate.

 

[Remainder
of Page Intentionally Left Blank]

 

    	 	7	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Common Stock Warrant to be signed on its behalf, in its corporate name, by its duly
authorized officer, all as of the day and year first above written.

 

	 	SURNA
    INC.
	 	 
	 	By:	 	 
	 	 	 	Chris
Bechtel, Chief Executive Officer
	 	 	 	 
	 	Address:	 	1780
    55th Street
	 	 	 	Boulder,
Colorado 80301

 

SIGNATURE
PAGE TO COMMON STOCK WARRANT

 

    	 

     

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

	To:	Surna
    Inc. 	Dated:
    _______________

 

The
undersigned, pursuant to the provisions set forth in the attached Warrant No. _______, hereby irrevocably elects to purchase _____
shares of the Common Stock covered by such Warrant and herewith makes payment of $ _________, representing the full purchase price
for such shares at the price per share provided for in such Warrant, together with all applicable transfer taxes, if any.

 

Payment
has been made in lawful money of the United States by:

 

	 	[  ]	Certified
check (enclosed herewith)
	 	 	 
	 	[  ]	Wire
transfer

 

The
shares of Common Stock to be issued will contain the restrictive legend under the Securities Act. Please indicate your preference
for the issuance of shares of Common Stock (must check one box only):

 

	 	[  ]	The
    shares of Common Stock should be issued in book entry form to be held at the Company’s transfer agent. The undersigned
    understands that, upon issuance of the shares, the undersigned will receive a transaction report reflecting such book entry
    issuance directly from the transfer agent.
	 	 	 
	 	[  ]	The
    shares of Common Stock should be issued in a physical certificate and delivered to the address shown below:

 

_______________________________

 

_______________________________

 

The
undersigned hereby certifies that it is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act.

 

	 	Signature:________________________________________
	 	 
	 	Name
(print):______________________________________
	 	 
	 	Title
    (if applicable):_________________________________ 
	 	 
	 	Entity
Name (if applicable):___________________________

 

    	 

     

    

 

Exhibit
b

 

ASSIGNMENT
FORM

 

FOR
VALUE RECEIVED, _________________________________________ hereby sells, assigns, and transfers all of the rights of the undersigned
under the attached Warrant with respect to the number of shares of Warrant Shares covered thereby set forth below, to:

 

	Name
                                         of Assignee
	 	Address/Email
                                         
	 	No.
                                         of Shares

	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

	Dated:	 	 	Signature:	 	
	 	 	 	 	 	
		 	 	Witness:EXECUTIVE
EMPLOYMENT AGREEMENT

 

This
Executive Employment Agreement (this “Agreement”) is made and entered into effective this 6th day
of September, 2017 by and between Surna Inc., a Nevada corporation whose address is 1780 55th Street, Suite A, Boulder,
Colorado 80301 (the “Company”) and Chris Bechtel, an adult resident of the State of Texas (the “Executive”).
The Executive and the Company may be referred to herein individually as a “Party” or collectively as the “Parties.”

 

AGREED
ACKNOWLEDGMENTS

 

A.
The Company is engaged in the development, design and distribution of cultivation technologies for controlled environment agriculture
for state-regulated cannabis cultivation facilities and traditional indoor agricultural facilities, including lighting, environmental
control and air sanitation designed to meet the specific environmental conditions required for indoor cultivation and to reduce
energy and water consumption (the “Business”).

 

B.
In connection with the Business, the Company manufactures or is developing, sells and delivers the following products and services:
(i) liquid-based process cooling and climate control systems, (ii) reflectors and lighting systems, including water-cooled reflectors,
(iii) a full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to indoor
cultivation facility conditions, (iv) automation and control devices, systems and technologies used for environmental, lighting
and climate control in indoor cultivation facilities, (v) a comprehensive, hybrid cultivation facility design and building utilizing
sunlight and a high-power LED lighting system, and (vi) and other products, services, and technologies now or hereafter developed
related to the foregoing (collectively, the “Products”)

 

C.
The Business of the Company is highly competitive and requires the creation of intimate and prolonged relationships with the Company’s
customers because of the custom products developed for individual customers, and the significance of adapting to the marketing
plans continually being created by these customers.

 

D.
The Company has invested and will continue to invest considerable sums of time, money, and other resources in developing the confidence
and loyalty of its customers and potential customers and to recruit, train, support and compensate its employees and potential
employees. In addition, the Company expends significant amounts of time and money to attract, identify, locate, and establish
contacts and business relationships with prospective customers. The loss of these existing and prospective relationships with
customers, and with existing and potential employees, will cause substantial and irreparable harm to the Company, which cannot
be accurately or adequately compensated by money alone.

 

E.
The Company desires to retain the services of the Executive as a member of the Company’s management team. The Executive
desires to continue such employment and commits to devote all of the Executive’s business time and attention to services
benefiting the Company. Both the Executive and the Company wish to enter into this Agreement to set forth the terms and conditions
of the Executive’s employment with the Company.

 

F.
The Executive acknowledges that, in connection with the execution of this Agreement, the Executive is receiving new and valuable
consideration from the Company including, without limitation, an incentive bonus program and the grant of certain restricted stock
units and non-qualified stock options under the Company’s 2017 Equity Incentive Plan, as adopted by the Company’s
Board of Directors (the “Board”) on August 1, 2017, as may be modified and amended by the Company from time
to time (the “EIP”).

 

G.
The Executive acknowledges that, in the course of the Executive’s employment with the Company, the Executive will frequently
come into contact with the Company’s customers and suppliers to such an extent that the Executive may be able to control
or direct, in whole or in part, the business and relationships between the Company and its customers and suppliers. Accordingly,
the Company reposes its trust in the Executive not to disrupt or otherwise misappropriate the customer and supplier relationships
developed and/or supported by the Company.

 

    	 

     

    

 

H.
The Executive will also, during the course of the Executive’s employment with the Company, have frequent and close contact
with the Company’s other executive managers, salespeople, and key staff employees. As a result of the Executive’s
position, the Executive will acquire and have access to confidential information concerning the Company’s employees, prospective
employees, customers, suppliers, and prospective customers and suppliers that is not easily or generally available to the Company’s
competitors.

 

I.
The Executive acknowledges that, by virtue of the Executive’s position with the Company, the Executive will have access
to certain secret and confidential business data and information belonging to the Company including, but not limited to: marketing
plans, financial strategies, market surveys and assessments, customer and Company technical information, financial statements,
budget data, personnel records, customer profiles and purchase requirements, product design, engineering and technical specifications,
pricing plans and strategies, sales contracts and proposals, private and confidential discussions with executive managers, legal
advice and strategies, performance evaluations, price schedules from suppliers, litigation and planned litigation, capital needs,
lists of customers and potential customers, hiring and training goals, internal operation and production reports and schedules,
compensation packages, customer account projections, licenses, promotional plans and information, corporate policies for internal
operations, bids and proposals by suppliers and to customers, identities and personal profiles of key persons at customers and
potential customers, expense data by customer, and other confidential and sensitive business information developed and maintained
by the Company.

 

J.
The Company has a valuable and proprietary interest in the confidential information described in paragraph I above and has expended
considerable time and money to safeguard and protect such information from direct or indirect divulgence of same by its employees,
including the Executive. In addition, as part of the Company’s relationship with each of its customers, the Company assures
customers that the unique, confidential, and secret information shared by customers with the Company will be protected from disclosure
to and unauthorized use by others. Any divulgence of such information will constitute an irreparable injury to the Company and
the Company’s customers.

 

K.
The Executive acknowledges that (i) the Executive’s position with the Company is one of great trust and confidence requiring
that the Executive exercise a high degree of loyalty, honesty, and integrity, (ii) the Executive has and will receive substantial
and adequate monetary consideration and benefits pursuant to this Agreement, (iii) the Executive has read and understood the terms
of this Agreement and signed the same as a free and voluntary act, and (iv) the Executive understands that there is no need to
continue employment with the Company, but the Executive has freely chosen to enter into this Agreement because of a desire to
take advantage of the specific and unique opportunities offered by continued employment with the Company and the additional benefits
provided for herein.

 

AGREEMENTS

 

In
consideration of the Agreed Acknowledgments and the mutual covenants and agreements set forth in this Agreement, the Parties agree
as follows:

 

1.
Acknowledgments. The acknowledgments set forth above are accurate and are hereby incorporated by reference in this
Agreement.

 

    	2

     

    

 

2.
Employment. The Company hereby employs the Executive and the Executive hereby accepts employment with the Company
on the terms and conditions set forth in this Agreement.

 

3.
Duties. During the Term (as defined below), the Executive shall be employed by the Company as the Chief Executive
Officer and President and, as such, the Executive shall have such responsibilities and authority as are customary for such position
of a company of similar size and nature as the Company as may be assigned from time to time by the Board. The Executive will also
hold such other executive officer positions as the Board may appoint from time to time. The Executive shall faithfully perform
for the Company the duties of such position and shall report directly to the Board. At all times during the Term, the Executive
shall adhere to all of the Company’s policies, rules and regulations governing the conduct of its employees, including without
limitation, any compliance manual, code of ethics, employee handbook or other policies adopted by the Company from time to time.
The Company and the Executive acknowledge that the Parties have entered into that certain Indemnification Agreement dated May
31, 2017 (“D&O Indemnity Agreement”). Effective as of the Effective Date, the Executive hereby resigns
from the Audit Committee of the Board.

 

4.
Extent of Services. Except for illnesses and vacation periods, the Executive shall devote the Executive’s
full business time and attention and the Executive’s best efforts to the performance of the Executive’s duties and
responsibilities under this Agreement. Notwithstanding the foregoing, the Executive may participate in charitable, academic, community
religious or other non-profit activities, and in trade or professional organizations, and engage and participate in the specific
activities listed in Exhibit A hereto (the “Permitted Activities”) or such other activities as
specifically agreed to in writing by the Company in advance from time to time in the Company’s sole discretion, provided
that all of the Executive’s activities outside of the Executive’s duties to the Company, individually or in the aggregate,
shall comply with the Company’s conflict of interest policies and corporate governance guidelines as in effect from time
to time, do not otherwise interfere with the Executive’s duties and responsibilities to the Company, and do not compete
with or adversely affect the Business of the Company. Subject to the provisions of Section 11 herein, the Executive may make any
passive investment in any publicly traded entity, or own five percent (5%) or less of the issued and outstanding voting securities
of any entity, provided, in any event, that the Executive is not obligated or required to, and shall not in fact, devote any consulting
or managerial effort or services in connection therewith, except for the Permitted Activities.

 

5.
Place of Performance. The Executive will perform the Executive’s duties for the Company from the Company’s
corporate offices in Boulder, Colorado (the “Corporate Office”), except that: (i) the Employee may continue
to reside in Houston, Texas, but will commute to, perform the duties hereunder at, the Corporate Office at least fifty percent
(50%) of the working days with the Employee being allowed to work from the Employee’s residence in Houston, Texas for the
other fifty percent (50%) of the working days, and (ii) the Employee will travel to perform services as required for the proper
performance of the Employee’s duties under this Agreement.

 

6.
Term; At-Will Employment; Termination. This Agreement and the Executive’s employment hereunder shall commence
on August 17, 2017 (the “Effective Date”) and, subject to earlier termination as provided in this Section 6,
shall continue in full force and effect thereafter until December 31, 2019 (the “Initial Term”) and, by mutual
written agreement of the Parties, may be extended for a term of one (1) additional year (an “Extended Term”)
at the end of the Initial Term, and an additional one (1) year Extended Term at the end of each Extended Term (the last day of
the Initial Term and each such Extended Term is referred to herein as a “Term Date”). Notwithstanding any other
provision of this Agreement to the contrary, either Party may terminate this Agreement, at any time, with or without Cause (as
defined herein), by providing the other Party with 30-days’ prior written notice. During the Term (as defined below) and
for so long as the Executive is employed by Company, the Executive shall be an at-will employee of Company. The employment of
the Executive by the Company shall terminate immediately upon death of the Executive. Any termination of the Executive’s
employment by the Company or by the Executive (other than termination pursuant to death) shall be communicated by written notice
of termination to the other Party hereto in accordance with this Agreement. For purposes of this Agreement, “Term”
shall mean the actual duration of the Executive’s employment hereunder, taking into account any extensions or any termination
of employment pursuant to this Section 6, and “Date of Termination” shall mean the date the Executive’s
employment is terminated in accordance with this Section 6.

 

    	3

     

    

 

7.
Compensation.

 

a.
Salary. The Company shall pay the Executive an annualized base salary (the “Base Salary”) of
$180,000 per year, which shall be payable in equal installments in accordance with the Company’s standard payroll practice
from time to time, less customary or legally required withholdings and deductions, for periods actually worked by the Executive.

 

b.
Restricted Stock Units. Upon execution of this Agreement or as soon as practicable thereafter, subject to the approval
of the Board (or an authorized committee thereof), as compensation for entering into this Agreement, the Company shall grant 3,000,000
Restricted Stock Units (as defined in the EIP) to the Executive, which shall subject to the terms of the EIP and a separate Restricted
Stock Unit Agreement to be executed by the Company and the Executive, substantially in the form attached hereto as Exhibit
B. The Restricted Stock Units shall be valued at Fair Market Value (as defined in the EIP) on the date such Restricted
Stock Units vest and, upon vesting, the Executive will receive one share of the Company’s common stock (“Common
Stock”) for each vested Restricted Stock Unit (with no cash purchase price to be paid by the Executive for such share
of Common Stock). As a condition to the Company’s obligations with respect to the Restricted Stock Units (including, without
limitation, any obligation to deliver any shares of Common Stock upon vesting of the Restricted Stock Units), the Executive shall
make arrangements satisfactory to the Company to pay to the Company any federal, state, local, or foreign taxes of any kind required
to be withheld with respect to the delivery of shares of Common Stock corresponding to such Restricted Stock Units. The Restricted
Stock Units shall vest as follows:

 

	

    Number of Restricted Stock Units	 	Vesting
    Schedule
	 

        1,500,000
        shares

         
	 	 

        Vest
        on March 31, 2019, if the Company’s 2018 revenue is at least $18 million (provided the Executive is employed by,
        or providing services to, the Company at December 31, 2018)

        

	 	 	 
	 

        1,500,000
        shares

         
	 	
        Vest
        on March 31, 2020, if the Company’s 2019 revenue is at least $25 million (provided the Executive is employed by,
        or providing services to, the Company at December 31, 2019)

        

 

Any
Restricted Stock Units that do not vest on the date specified above due to failure to meet the applicable performance threshold
will be forfeited on such date.

 

For
purposes of determining the vesting of the Restricted Stock Units, which are subject to a revenue threshold for 2018 and 2019,
the achievement of such revenue threshold will be based on the Company’s annual revenue as reported in the Company’s
financial statements for such year, as audited by the Company’s accounting firm, excluding any revenue attributable to any
business acquired by the Company after the Effective Date.

 

    	4

     

    

 

c.
Incentive Bonus Program. The Executive shall be eligible to receive an annual incentive bonus (each an “Annual
Incentive Bonus”) for each completed year of employment during the Term in accordance with a bonus policy adopted by
the Board (or an authorized committee thereof), as may be amended or modified from time to time. The bonus policy will provide
that the Executive shall be entitled to earn an Annual Incentive Bonus for such completed year of employment based on performance
criteria determined in the sole discretion of the Board. The Annual Incentive Bonus for a completed year of employment shall be
paid within forty-five (45) days following the end of the completed year. Other than as set forth in Section 9, the Executive
must be employed by, or be providing services to, the Company or an affiliate of the Company on the date an Annual Incentive Bonus
is to be paid to be eligible to receive the Annual Incentive Bonus for such completed year of employment. Payment of the Annual
Incentive Bonus may be made in the form of cash, stock bonus (issued pursuant to the EIP), or a combination thereof, as determined
in the sole discretion of the Board (or an authorized committee thereof). As a condition to the Company’s obligations with
respect to any stock bonus (including, without limitation, any obligation to deliver any shares of Common Stock with respect to
any stock bonus), the Executive shall make arrangements satisfactory to the Company to pay to the Company any federal, state,
local, or foreign taxes of any kind required to be withheld with respect to the delivery of shares of Common Stock with respect
to such stock bonus.

 

In
lieu of the Annual Incentive Bonus for each completed year of employment during the Initial Term, which the Executive acknowledges
that the Executive will not be eligible to receive, the Company has adopted a special incentive bonus program under which the
Executive will be eligible to receive an incentive bonus on each December 31 and June 30 during the Initial Term (the “Special
Incentive Bonus”). For each of the five (5) Special Incentive Bonuses payable during the Initial Term, the Executive
shall be eligible to receive a bonus of 1,000,000 shares of the Company’s Common Stock, provided the Board has determined,
in its sole discretion, that the Executive’s performance has been average or better for such Special Incentive Bonus period.
The Special Incentive Bonus for each period shall be paid within forty-five (45) days following December 31 or June 30, as applicable.
Other than as set forth in Section 9, the Executive must be employed by, or providing services to, the Company or an affiliate
of the Company on the date the Special Incentive Bonus is to be paid to be eligible to receive the Special Incentive Bonus for
such period. As a condition to the Company’s obligations with respect to each Special Incentive Bonus (including, without
limitation, any obligation to deliver any shares of Common Stock with respect to any Special Incentive Bonus), the Executive shall
make arrangements satisfactory to the Company to pay to the Company any federal, state, local, or foreign taxes of any kind required
to be withheld with respect to the delivery of shares of Common Stock with respect to such Special Incentive Bonus.

 

d.
Non-qualified Stock Options. In consideration of the grant of the foregoing Restricted Stock Units and the eligibility
for the Special Incentive Bonus, the Company and the Executive hereby agree that the non-qualified stock options to purchase 900,000
shares of the Company’s common stock, which were granted to the Executive as an equity retention award in connection with
the Executive’s appointment to the Board on August 8, 2017, are hereby terminated and cancelled effective as of the date
of this Agreement.

 

e.
Clawback. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based compensation,
or any other compensation, paid to the Executive pursuant to this Agreement or any other agreement or arrangement with the Company
which is subject to recovery under any law, governmental regulation, or stock exchange listing requirement, will be subject to
such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange listing
requirement.

 

    	5

     

    

 

f.
Change of Control. In the event that there is a “Change in Control” (as defined below) prior
to the date on which the Restricted Stock Units become fully vested, then 100% of the Restricted Stock Units not already vested
shall become vested on the date of the Change of Control (other than those Restricted Stock Units that have been previously forfeited
due to failure to meet the performance threshold), provided the Executive is employed by, or providing services to, the Company
on the date immediately preceding the date of the Change of Control. In the event of a Change of Control prior to December 31,
2019, then the remaining Special Incentive Bonuses related to any Special Incentive Bonus period ending after the date of the
Change of Control shall become due and payable on the date of the Change of Control, provided the Executive is employed by, or
providing services to, the Company on the date immediately preceding the date of the Change of Control. A “Change of
Control” means a reorganization, merger, statutory share exchange, or consolidation or similar transaction involving
the Company, or a sale or other disposition of all or substantially all of the assets of the Company, unless, following such transaction,
all or substantially all of the individuals and entities who were the beneficial owners of the Company’s equity and voting
securities immediately prior to such transaction beneficially own, directly or indirectly, more than fifty percent (50%) of the
value of the then outstanding equity securities and the combined voting power of the then outstanding voting securities

 

8.
Fringe Benefits. The Company shall provide the following benefits to the Executive during the Term:

 

a.
Executive Benefit Plans. The Executive will be eligible to participate in any employee benefit plans including,
without limitation, group insurance, profit sharing and 401(k) plans, sponsored generally by the Company for its employees as
may be offered from time to time. Notwithstanding the foregoing, the Company may modify or terminate any employee benefit plan
at any time.

 

b.
Vacation. The Executive shall accrue in accordance with the Company’s vacation policy as in effect from time
to time twenty (20) days per year of paid vacation time, provided that, any earned but unused vacation in a year may not be carried
forward to future years.

 

c.
Personal Days, Sick Leave and Holidays. The Executive shall be entitled to receive paid personal days, sick days
and holidays under the guidelines established by the Company from time to time for the Company’s executive and management
employees, provided that, any earned but unused personal and sick days in a year may not be carried forward to future years.

 

d.
Business Expense Reimbursement. Subject to the Company’s policies and procedures for the reimbursement of
business expenses incurred by its executive and management employees, the Company shall reimburse the Executive for reasonable
expenses incurred by the Executive in connection with the performance of the Executive’s duties pursuant to this Agreement,
including, but not limited to, travel expenses, professional conventions or similar professional functions and other reasonable
business expenses. The Executive agrees to provide the Company with receipts and/or documentation sufficient to permit the Company
to take its full business expense deduction. The Company shall have no obligation to reimburse the Executive for expenses claimed
if the Executive does not provide sufficient receipts and/or documentation. The Executive shall submit requests for reimbursement
of business expenses at least once every month. The Executive shall not be entitled to a corporate credit card, and any frequent
flyer miles earned for travel contemplated under this Agreement shall be owned by the Executive. The Parties acknowledge and agree
that, during the Term: (i) the Executive will be reimbursed for air travel and airport parking to commute to and from Houston
and Denver, (ii) all lodging, meal and food costs incurred by the Executive while commuting or working from the Corporate Office
shall be reimbursed, (iii) while working from the Corporate Office, the Executive will be reimbursed for rental car and fuel costs,
(iv) all costs and expenses reimbursable under this sentence shall be subject the Company’s reimbursement policies and procedures,
and (v) the Executive shall use the Executive’s best efforts to minimize the costs and expenses subject to reimbursement
under this sentence, and the Company shall only be required to reimburse reasonable costs and expenses.

 

    	6

     

    

 

e.
Miscellaneous Benefits. The Executive is also entitled to receive any other fringe benefits that Company may from
time to time make available generally to its management employees.

 

9.
Effects of Termination.

 

a.
Accrued Benefits. If the employment of the Executive should terminate at the election of the Company with or without
Cause, at the election of the Executive, due to the Executive’s death, or upon expiration of the Term, then the Company
will pay or provide to the Executive or, in the event of the Executive’s death, to the estate of the Executive:

 

i.
any earned and accrued but unpaid Base Salary through the Date of Termination payable in accordance with the Company’s normal
payroll practices;

 

ii.
reimbursement for any unreimbursed business expenses incurred through the Date of Termination in accordance with Section 8(d);
and

 

iii.
all other applicable payments or benefits to which the Executive shall be entitled under, and paid or provided in accordance with,
the terms of any applicable arrangement, plan or program under Section 8(a)-(d) (collectively, Sections 9(a)(i)-(iii), payable
in accordance with this Section 9(a), shall be hereafter referred to as the “Accrued Benefits”).

 

b.
Death Benefit. If the employment of the Executive should terminate during the Term due to the Executive’s
death, then the Company will pay or provide to the estate of the Executive (in addition to the Accrued Benefits payable under
Section 9(a)), subject to Section 9(e):

 

i.
any accrued but unpaid Annual Incentive Bonus for any completed year of employment prior to the year of the Executive’s
death, payable when the applicable Annual Incentive Bonus for such completed year of employment would have otherwise been paid;
and

 

ii.
any accrued but unpaid Special Incentive Bonus for any completed period of employment prior to the Executive’s death, payable
when the applicable Special Incentive Bonus for such completed period of employment would have otherwise been paid; and

 

iii.
the unvested Restricted Stock Units that are scheduled to vest under Section 7(b) on the March 31st immediately following
the calendar year in which the Executive dies shall continue to vest in accordance with the vesting schedule set forth in Section
7(b) notwithstanding the Executive’s death, provided that, the Company achieves the applicable full year revenue
threshold for such vesting for the calendar year in which the Executive dies.

 

All
other unvested Restricted Stock Units at the time of the Executive’s death under Section 7(b) shall be forfeited.

 

c.
Termination by the Company without Cause. If the employment of the Executive should terminate at the election of
the Company without Cause, the Company will pay or provide to the Executive (in addition to the Accrued Benefits payable under
Section 9(a)), subject to Sections 9(e) and 10:

 

i.
continued payment of the Executive’s Base Salary for a period equal to the lesser of thirty (30) days from the Date of Termination
or the then applicable Term Date, whichever occurs first, payable in accordance with the Company’s normal payroll practices
(but off employee payroll) (the “Severance Payments”); provided that, the first payment of the Severance Payments
shall be made on the fifteenth (15th) day after the Date of Termination, and will include payment of any amount of
the Severance Payments that were otherwise due prior thereto;

 

    	7

     

    

 

ii.
any accrued but unpaid Annual Incentive Bonus for any completed year of employment prior to the year of the Executive’s
termination, payable when the applicable Annual Incentive Bonus for such completed year of employment would have otherwise been
paid; and

 

iii.
any accrued but unpaid Special Incentive Bonus for any completed period of employment prior to the Executive’s termination,
payable when the applicable Special Incentive Bonus for such completed period of employment would have otherwise been paid; and

 

iv.
the unvested Restricted Stock Units that are scheduled to vest under Section 7(b) on the March 31st immediately following
the calendar year in which the Executive’s termination occurred shall continue to vest in accordance with the vesting schedule
set forth in Section 7(b) notwithstanding the Executive’s termination of employment with the Company, provided that,
the Company achieves the applicable full year revenue threshold for such vesting for the calendar year in which the Executive’s
termination occurred.

 

All
other unvested Restricted Stock Units at the time of the Executive’s termination of employment with the Company under Section
7(b) shall be forfeited.

 

For
purposes of this Agreement, the term “Cause” means that the Executive: (i) has been convicted of, or entered
a plea of guilty or “nolo contendere” to, a felony or a crime involving moral turpitude causing material harm
to the standing and reputation of the Company, (ii) violated any of the Executive’s obligations under this Agreement, any
award agreement under the EIP, any proprietary rights, non-competition, non-disclosure or other restrictive covenant agreements
in effect between the Executive and the Company, including such agreements in this Agreement, which are demonstrably willful or
deliberate on the Executive’s part, (iii) has willfully or deliberately failed to perform the Executive’s material
duties assigned by, or to follow the lawful orders and direction of, the Board (other than by reason of illness or temporary disability),
(iv) has engaged in illegal conduct, gross misconduct, fraud or material dishonesty in connection with the Business of the Company,
(v) has engaged in willful misappropriation or embezzlement of any of the Company’s funds or property, or (vi) has engaged
in conduct that violated the Company’s then existing written internal policies or procedures and which is detrimental to
the Business or reputation of the Company. Any of the aforesaid clauses (ii), (iii) and (vi) may be cured by the Executive, if
curable, if cured within fifteen (15) days after receipt by the Executive of written notice of the same. In the event such acts
or omissions are capable of being cured, the effective date of termination, in the event of the Executive’s failure to cure,
must be at least fifteen (15) days after such notice of termination to afford the Executive the ability to cure the same. The
Company may place the Executive on paid leave for up to sixty (60) consecutive days while it is determining whether there is a
basis to terminate Executive’s employment for Cause.

 

d.
Expiration of Term. In the event that the Initial Term expires on December 31, 2019 without being extended by the
Parties, the Company will pay or provide to the Executive (in addition to the Accrued Benefits payable under Section 9(a)), subject
to Section 9(e):

 

i.
any accrued but unpaid Special Incentive Bonus for the six-month period ended December 31, 2019, payable when the applicable Special
Incentive Bonus for such completed period of employment would have otherwise been paid; and

 

ii.
the unvested Restricted Stock Units that are scheduled to vest under Section 7(b) on March 31, 2020 shall continue to vest in
accordance with the vesting schedule set forth in Section 7(b) notwithstanding the Executive’s termination of employment
with the Company, provided that, the Company achieves the full year revenue threshold for such vesting for the 2019 calendar
year.

 

    	8

     

    

 

e.
Release. Any payments or benefits by the Company required under Sections 9(b), 9(c), and 9(d) shall be conditioned
on and shall not be payable unless the Company receives from the Executive (or, in the event of the Executive’s death, the
estate of the Executive) within thirty (30) days of the Date of Termination a fully effective and non-revocable written release
in form and substance reasonably acceptable to the Company of any and all past, present or future claims that the Executive (or,
in the event of the Executive’s death, the estate of the Executive) may have against the Company or any of its affiliates
and any of their respective officers, directors and other related parties (all claims released in this Section 9(e) being referred
to as the “Released Claims”), provided, however, that the Released Claims shall not include any claim by the
Executive for indemnification from the Company relating to any act or omission prior to the Date of Termination, in each instance
to the extent the Executive would have the right to be indemnified therefor under (and not otherwise prohibited or restricted
by) (i) the laws of the State of Nevada, (ii) any Federal law applicable to the Company or the Executive, (iii) the Company’s
articles of incorporation or bylaws, as amended, and (iv) the D&O Indemnity Agreement. The Company agrees to provide a form
of release within seven (7) days of the Date of Termination.

 

f.
Termination of Authority. Immediately upon the Executive terminating or being terminated from the Executive’s
employment with the Company for any reason, notwithstanding anything else appearing in this Agreement or otherwise, the Executive
will stop serving the functions of the Executive’s terminated or expired position(s), including but not limited to any director
or officer positions at the Company or any of its affiliates, and shall be without any of the authority or responsibility for
such position(s).

 

10.
Section 409A.

 

a.
Although the Company does not guarantee the tax treatment of any payments under this Agreement, the intent of the Parties is that
the payments and benefits under this Agreement be exempt from, or comply with, Section 409A of the Internal Revenue Code of 1986,
as amended (the “Code”), and all Treasury Regulations and guidance promulgated thereunder (“Code Section
409A”) and to the maximum extent permitted this Agreement shall be limited, construed and interpreted in accordance
with such intent. In no event whatsoever shall the Company or its affiliates or their respective officers, directors, employees
or agents be liable for any additional tax, interest or penalties that may be imposed on the Executive by Code Section 409A or
damages for failing to comply with Code Section 409A.

 

b.
Notwithstanding any other provision of this Agreement to the contrary, to the extent that any reimbursement of expenses constitutes
“deferred compensation” under Code Section 409A, such reimbursement shall be provided no later than December 31st
of the year following the year in which the expense was incurred (or, where applicable, no later than such earlier time
required by this Agreement). The amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement
in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits
provided in any other year.

 

c.
For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)),
the right to receive payments in the form of installment payments shall be treated as a right to receive a series of separate
payments and, accordingly, each installment payment shall at all times be considered a separate and distinct payment. Whenever
a payment under this Agreement may be paid within a specified period, the actual date of payment within the specified period shall
be within the sole discretion of the Company.

 

d.
Notwithstanding any other provision of this Agreement to the contrary, if at the time of the Executive’s separation from
service (as defined in Code Section 409A), the Executive is a “Specified Executive”, then the Company will defer the
payment or commencement of any nonqualified deferred compensation subject to Code Section 409A payable upon separation from service
(without any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date that is six (6)
months following separation from service or, if earlier, the earliest other date as is permitted under Code Section 409A (and
any amounts that otherwise would have been paid during this deferral period will be paid in a lump sum on the day after the expiration
of the six (6)- month period or such shorter period, if applicable). The Executive will be a “Specified Executive”
for purposes of this Agreement if, on the date of the Executive’s separation from service, the Executive is an individual
who is, under the method of determination adopted by the Company designated as, or within the category of executives deemed to
be, a “Specified Executive” within the meaning and in accordance with Treasury Regulation Section 1.409A-1(i). The
Company shall determine in its sole discretion all matters relating to who is designated as a “Specified Executive”
and the application of and effects of the change in such determination.

 

    	9

     

    

 

e.
Notwithstanding anything in this Agreement or elsewhere to the contrary, a termination of employment shall not be deemed to have
occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits that constitute
“non-qualified deferred compensation” within the meaning of Code Section 409A upon or following a termination of the
Executive’s employment unless such termination is also a “separation from service” within the meaning of Code
Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination
of employment” or like terms shall mean “separation from service” and the date of such separation from service
shall be the date of termination for purposes of any such payment or benefits.

 

11.
Activity Restrictions; Executive Covenants.

 

a.
Purpose. As previously acknowledged, the Company has invested heavily in its information systems, personnel, product
development, customers, and customer development. As a member of the Company’s executive management group, the Executive
is entrusted with the fruits of these investments and the decisions to be made regarding similar future investments. In order
to participate in the benefits of a highly compensated position of trust with the Company, the Company requires a written commitment
from key employees that its trust will not be misplaced and its investments lost or damaged. Accordingly, the Executive makes
the following promises regarding the Executive’s activities.

 

b.
Best Efforts. The Executive will at all times perform all of the Executive’s assigned duties faithfully and
exert the Executive’s best efforts to fully perform those duties pursuant to the express and implicit terms of this Agreement
to the reasonable satisfaction of the Company. During employment, the Executive will not engage in or become interested in any
calling, activity, or other business which is or may be contrary to or in competition with the interests and welfare of the Company.

 

c.
Inventions; Intellectual Property.

 

i.
Inventions. Every invention and improvement conceived, invented or developed by the Executive relating to or useable
in the Business then being carried on or actively contemplated by the Company now existing or hereafter developed shall become
the exclusive property of the Company. With respect to all inventive ideas originated or developed by the Executive which relate
to the Business during the Term hereof, or as to which the Executive has acquired information as a result of the Executive’s
employment with the Company, and all patents obtained on such inventive ideas, (a) the Executive agrees to disclose and assign,
without charge, all such inventive ideas and any patents obtained thereon to the Company, but without expense to the Executive,
(b) the Executive agrees that all such inventive ideas and any patents thereof shall be the exclusive property of the Company,
and (c) the Executive will, at any and all times, furnish such information and assistance and execute such applications and other
documents as may be advisable in the opinion of the Company to obtain both domestic and foreign patents, title to which is to
be vested in the Company, and the Executive shall give the Company the full and exclusive power to prosecute all such applications
and all proceedings in connection therewith.

 

    	10

     

    

 

ii.
Intellectual Property. The Executive shall promptly disclose to the Company or any successor or assign, and grant
to the Company or its successors and assigns without any separate remuneration or compensation other than that received by the
Executive in the course of the Executive’s employment, the Executive’s entire right, title and interest in and to
any and all inventions, developments, discoveries, models, or business plans or opportunities, or any other intellectual property
of any type or nature whatsoever related to the Business or the Products (“Intellectual Property”), developed
by the Executive during the period of the Executive’s employment by the Company or its affiliates and whether developed
by the Executive during or after business hours, or alone or in connection with others, that is in any way related to the Business
of the Company, its successors or assigns. This provision shall not apply to books or articles authored by the Executive during
non-work hours, consistent with the Executive’s obligations under this Agreement, so long as such books or articles (a)
are not funded in whole or in part by the Company, and (b) do not contain any confidential information or Intellectual Property
of the Company. The Executive agrees, at the Company’s expense, to take all steps necessary or proper to vest title to all
such Intellectual Property in the Company, and cooperate fully and assist the Company in any litigation or other proceedings involving
any such Intellectual Property.

 

d.
Non-solicitation of Business. During the Term hereof and for a period of one (1) year after the termination or expiration
of this Agreement, regardless of who initiated the termination, the Executive will not, directly or indirectly, solicit, interfere
with, or divert away from the Company any customer of the Company who did any business with the Company during the Term hereof.

 

e.
Non-enticement of Personnel. During the Term hereof and for a period of one (1) year after the termination or expiration
of this Agreement, regardless of who initiated the termination, the Executive shall not, directly or indirectly, as an individual
or on behalf of any other person or entity, hire, solicit, recruit, or attempt to entice away from the Company or any customer
of the Company any person employed by or providing services to the Company or any customer of the Company. The Executive shall
not approach any such employees for such a prohibited purpose and shall not knowingly cooperate in any other person or entity’s
efforts to do so. The Company’s customers are third-party beneficiaries of this covenant and shall have standing to enforce
the terms of this Section 11(e) by seeking whatever equitable and legal remedies may be available to the Company hereunder.

 

f.
Confidentiality. The Executive shall not at any time during the Term hereof or at any time thereafter communicate,
divulge, disclose, take, or use for himself any information, knowledge, data, or materials that were disclosed or obtained by
the Executive during the Term (including, without limitation, any information and knowledge that was conceived, created, or developed
by the Executive during the course of the Executive’s employment with the Company) which is related to the Business and
the Products and is not already generally known in the Company’s trade by competitors. This restriction on confidential
information disclosure and use shall apply to knowledge or information which relates to the Business or the business of the Company’s
customers and is in the nature of a business secret of the Company or the Company’s customers. Included within the scope
of this restriction shall be the specific items identified in Section 11(h) hereof and any other information and matters designated
by the Company (verbally or in writing) to be confidential during the Term hereof. The Company’s customers are third-party
beneficiaries of the aforestated covenants in this Section 11(f) and shall have standing to enforce its terms and seek whatever
equitable or legal remedy that is necessary to repay or avoid harm to them, including, but not limited to, any remedy available
to the Company under this Agreement. The obligations of the Executive with respect to the disclosure and use of confidential information
under this Section 11(f) shall cease to the extent such information becomes generally known in the Company’s trade by competitors
through a means other than a breach of this Agreement by the Executive. In the event the Executive is required by any legal proceedings
to disclose confidential information, the Executive shall provide the Company with prompt notice thereof so that the Company may
seek an appropriate protective order and/or waive compliance by the Executive with the provisions hereof.

 

    	11

     

    

 

g.
Non-competition. During the Term hereof and for a period of one (1) year after the termination or expiration of
this Agreement, regardless of who initiated the termination, the Executive shall not, alone, or as an agent, employee, servant,
officer, partner or stockholder of any other corporation or business, directly or indirectly, engage in employment or business
activity which relates to the sale, manufacturing, or marketing of products which are competitive with, substantially similar
to, or serve the same function as the Products manufactured, marketed or sold by the Company either now or at any time during
the Term. This post-termination restriction is limited to activities in or directed at the geographic area located in North America
where the Company has sold or manufactured the Products at any time during the Term hereof. The Executive specifically agrees,
without limitation, that the Executive will not accept a similar position or perform the same or similar responsibilities or services
as performed for the Company for any business entity that is engaged in a business that is the same, or substantially similar
to, the Business (i.e., a competitor).

 

h.
Return of Company Materials. Upon request at any time during the Term hereof and without request at the time of
the termination or expiration of this Agreement, without regard for who initiated the termination, the Executive agrees to promptly
return (without retaining any copies, summaries, files or notes derived from source materials) all information and records regarding
the Business and the Products, whether or not created by the Executive during the Term hereof including, but not be limited to:
all financial, sales and purchase data for the Business and the Company’s customers, all financial statements and projections,
all marketing surveys and analyses, all strategic planning material, all data on the Company’s competitors, all customer
information, all records regarding prospective customers of the Company, all documents regarding pending or threatened litigation
involving the Company, all legal opinions, all personnel evaluations for the Company’s employees and outside vendors and
contractors, all computer hardware and software, all price lists and formulas, all pricing quotations or proposals, all lists
or compilations of customers and prospects, all promotional materials, all internal operating reports, all budgets and projections,
all information related to the Company’s product development and intellectual property, all product designs, specifications,
drawing, engineering, bills of material and other information related to the Products, all corporate and equipment manuals and
policies, all contracts with customers and suppliers, all supplier prices and quotations, all business correspondence, all catalogs
and product samples, all sensitive customer information, all sales reports and invoices, and all tangible and intangible property
owned by the Company.

 

i.
Non-Disparagement. During the Term and thereafter, the Executive shall not knowingly, directly or indirectly, make
negative comments or otherwise disparage the Company, any of its affiliates, or any of their respective officers, directors, employees,
shareholders, agents or businesses in any manner likely to be harmful to them or their business reputations or personal reputations.
The Company shall direct its officers, directors and senior management team to not disparage or encourage or induce others to
disparage the Executive. The foregoing shall not be violated by truthful statements in response to legal process, required governmental
testimony or filings, or administrative or arbitral proceedings (including depositions in connection with such proceedings), provided
that the Executive has given the Company prompt written notice of any such legal process and cooperated with the Company’s
efforts to seek a protective order.

 

j.
Executive’s Representations. The Executive represents and acknowledges that none of the activity restrictions
set forth in this Section 11 will prevent the Executive from obtaining employment, cause undue hardship, cause a relocation, or
adversely impact numerous other business and employment opportunities that are not affected by the existence of these restrictions.
The Executive further acknowledges that the Executive believes the foregoing restrictions to be reasonable and necessary to protect
the Company’s legitimate business interests. Any violation of the restrictions in this Section 11 can cause harm to the
Company of an irreparable nature for which money damages alone will not suffice. The Executive agrees that the Executive will
fully and promptly disclose to any person or entity with which the Executive becomes associated subsequent to the termination
or expiration of this Agreement all of the restrictions on the Executive’s post-termination activities. The Company shall
also have the right to disclose this Agreement to any business entity hiring or utilizing the services of the Executive subsequent
to the termination or expiration of this Agreement.

 

    	12

     

    

 

k.
Common Law and Trade Secrets. The Executive and the Company agree that nothing in this Agreement shall be construed
to limit or negate the common law of torts or trade secrets where it provides the Company with broader protection than that provided
herein.

 

l.
Tolling. In the event of any violation of the provisions of this Section 11, the Executive acknowledges and agrees
that the post-termination restrictions contained in this Section 11 shall be extended by a period of time equal to the period
of such violation, it being the intention of the Parties hereto that the running of the applicable post-termination restriction
period shall be tolled during any period of such violation.

 

m.
Rights and Remedies upon Breach. The Executive acknowledges and agrees that any breach by the Executive of any of
the provisions of Section 11 (the “Restrictive Covenants”) would result in irreparable injury and damage for
which money damages would not provide an adequate remedy. Therefore, if the Executive breaches, or threatens to commit a breach
of, any of the provisions of the Restrictive Covenants, the Company and its affiliates shall have the following rights and remedies,
each of which rights and remedies shall be independent of the other and severally enforceable, and all of which rights and remedies
shall be in addition to, and not in lieu of, any other rights and remedies available to the Company and its affiliates, under
law or in equity (including, without limitation, the recovery of damages):

 

i.
the right and remedy to have the Restrictive Covenants specifically enforced (without posting bond and without the need to prove
damages) by any court of competent jurisdiction, including, without limitation, the right to an entry against the Executive of
restraining orders and injunctions (preliminary, mandatory, temporary and permanent) against violations, threatened or actual,
and whether or not then continuing, of such covenants; and

 

ii.
the right and remedy to require the Executive to account for and pay over to the Company or any of its affiliates all compensation,
profits, monies, accruals, increments or other benefits (collectively, “Benefits”) derived or received by the
Executive as the result of any transactions constituting a breach of the Restrictive Covenants, and the Executive shall account
for and pay over such Benefits to the Company and, if applicable, its affected affiliates.

 

12.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Company’s successors
and assigns and the Executive’s personal or legal representatives, executors, administrators, heirs, distributees, devisees
and legatees. This Agreement shall not be assignable by the Executive, it being understood and agreed that this is a contract
for the Executive’s personal services. This Agreement shall not be assignable by the Company, except that the Company may
assign it to an affiliate of the Company and shall assign it in connection with a transaction involving the succession by a third
party to all or substantially all of the Company’s business and/or assets (whether direct or indirect and whether by purchase,
merger, consolidation, liquidation or otherwise). When assigned to a successor, the assignee shall assume this Agreement and expressly
agree to perform this Agreement in the same manner and to the same extent as the Company would be required to perform it in the
absence of such an assignment and the Company shall be released of all obligations hereunder. For all purposes under this Agreement,
the term “Company” shall include any successor to the Company’s business and/or assets that executes and delivers
the assumption agreement described in the immediately preceding sentence or that becomes bound by this Agreement by operation
of law. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns
as provided in this Section 12 and is not for the benefit of, nor may any provision hereof be enforced by, any other person, except
as otherwise set forth in this Agreement.

 

    	13

     

    

 

13.
Alternative Dispute Resolution.

 

a.
Coverage. Except as otherwise expressly provided in this Agreement or by law, this Section 13 is the sole and exclusive
method by which the Executive and the Company are required to resolve any and all disputes arising out of or related to the Executive’s
employment with the Company or the termination of that employment, each of which is referred to as “Employment-Related
Dispute,” including, but not limited to, disputes arising out of or related to any of the following subjects: (i) compensation
or other terms or conditions of the Executive’s employment, (ii) application or enforcement of any Company program or policy
to the Executive, (iii) any disciplinary action or other adverse employment decision of the Company or any statement related to
the Executive’s employment, performance or termination, (iv) any policy of the Company or any agreement between the Executive
and the Company, (v) disputes over the arbitrability of any controversy or claim which arguably is or may be subject to this Section
13, (vi) claims arising out of or related to any current or future federal, state or local civil rights laws, fair employment
laws, wage and hour laws, fair labor or employment standards laws, laws against discrimination, equal pay laws, wage and salary
payment laws, plant or facility closing or layoff laws, laws in regard to employment benefits or protections, family and medical
leave laws, and whistleblower laws, including by way of example, but not limited to, the federal Civil Rights Acts of 1866, 1871,
1964 and 1991, the Pregnancy Discrimination Act of 1978, the Age Discrimination in Employment Act of 1967, the Equal Pay Act of
1963, the Fair Labor Standards Act of 1938, the Americans with Disabilities Act of 1990, the Family and Medical Leave Act of 1993,
and the Executive Retirement Income Security Act of 1978, as they have been or may be amended from time to time, or (vii) any
other dispute arising out of or related to the Executive’s employment or the Executive’s termination.

 

b.
Negotiation; Mediation. Any Employment-Related Dispute asserted by one Party against the other Party shall be delivered
in writing to the other Party. During the fifteen (15)-day period following receipt of the assertion by the other Party, the Parties
shall attempt in good faith to negotiate a resolution of the Employment-Related Disputes so asserted. If the Employment-Related
Disputes so asserted cannot be settled through negotiation and remains unresolved after the fifteen (15)-day negotiation period,
the Executive or the Company may submit the dispute to mediation and the Parties shall attempt in good faith to resolve the dispute
by mediation, under the mediation procedure of the American Arbitration Association (“AAA”). Unless the Parties
agree otherwise in writing, the mediation shall be conducted by a single mediator, and the mediator shall be selected from an
appropriate AAA panel pursuant to the AAA rules, respectively. The mediation shall be conducted in Denver, Colorado. Unless the
Parties agree otherwise, the cost of the mediator’s professional fees and expenses and any reasonable administrative fee
will be shared and paid equally by the Parties, and each Party shall bear its own attorneys’ fees and costs of the mediation.

 

c.
Binding Arbitration. If the Employment-Related Disputes so asserted cannot be settled through mediation and remains
unresolved thirty (30) days after the appointment of a mediator, the Executive or the Company may submit the dispute to arbitration
and the dispute shall be settled in arbitration. Notice of a demand to arbitrate a dispute by either Party shall be given in writing
to the other at their last known address. Arbitration shall be commenced by the filing by a party of an arbitration demand with
the AAA in its office in Denver, Colorado. The arbitration and resolution of the dispute shall be resolved by a single arbitrator
appointed by the AAA pursuant to AAA rules. The arbitration shall in all respects be governed and conducted by applicable AAA
rules, and any award and/or decision shall be conclusive and binding on the parties. The arbitration shall be conducted in Denver,
Colorado regardless of the particular plant or facility of the Parties. The arbitrator shall supply a written opinion supporting
any award, and judgment may be entered on the award in any court of competent jurisdiction. Each Party shall pay its own fees
and expenses for the arbitration except for any costs and charges imposed by the AAA which may be assessed against the losing
Party by the arbitrator. Any fees of the arbitrator for the arbitrator’s services shall in all events be shared and paid
equally by the Parties.

 

    	14

     

    

 

d.
Equitable Relief. In the event that preliminary or permanent injunctive relief is necessary or desirable in order
to prevent a Party from acting contrary to this Agreement or to prevent irreparable harm prior to a confirmation of an arbitration
award, including without limitation as provided under Section 14(h) hereof, then either Party is authorized and entitled to commence
a lawsuit solely to obtain equitable relief against the other pending the completion of the arbitration in a court having jurisdiction
over the Parties. All rights and remedies of the parties shall be cumulative and in addition to any other rights and remedies
obtainable from arbitration.

 

e.
Severability. In the event that any court or arbitrator finds or holds any restriction contained in this Agreement,
including the Restrictive Covenants, to be unreasonable, invalid, or unenforceable, then it is the express intent of the Parties
that the court or arbitrator so holding shall modify or amend the offending restriction or restrictions in any reasonable fashion
so as to render it or them enforceable to the fullest extent possible under prevailing law. In the event that any restriction
is deemed void and unenforceable and not suitable or capable of being so modified, then such restriction shall be severed. Each
term and provision of this Agreement is and shall be construed as severable in whole or in part, and, if any provision or the
application thereof to particular circumstances should be invalid, illegal, or unenforceable, then the remaining terms and provisions
shall not be affected and shall remain fully enforceable. An adjudication or finding of invalidity or unenforceability for one
jurisdiction of any particular provision shall not invalidate or void such provision in any other jurisdiction. It is the express
intent of the Parties that all restrictions imposed by this Agreement be construed and applied to avoid legal nullities and with
a view towards enforcement whenever possible

 

14.
Miscellaneous.

 

a.
Time of the Essence. Time is of the essence with respect to this Agreement. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein shall not be a business day (i.e, a Saturday, Sunday
or federal holiday), then such action may be taken or such right may be exercised on the next succeeding business day.

 

b.
Entire Agreement. This Agreement constitutes the entire understanding or agreement between the Company and the Executive
relating to the subject matter hereof and there is no understanding or agreement, oral or written, which is not set forth herein.
This Agreement supersedes and replaces any prior employment agreement or understanding, oral or written, between the Company and
the Executive. This Agreement may only be amended by a writing signed by the Company and the Executive.

 

c.
Waiver. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed by the Parties. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any Party to exercise any right hereunder in any manner impair the exercise
of any such right.

 

d.
Construction. In the event of a conflict or ambiguity created between the Company’s current personnel manual
for all employees and this Agreement, it is agreed that this Agreement shall control. No policies, procedures, or statements of
any nature by the Company shall modify this Agreement or be construed to create express or implied obligations to the Executive.
The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting
this Agreement. The Parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
this Agreement and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the
drafting Party shall not be employed in the interpretation of this Agreement or any amendments thereto. The word “including”
shall be construed to include the words “without limitation.” In this Agreement, unless the context otherwise requires,
references to the singular shall include the plural and vice versa. The word “Company” shall be construed to include
the Company and its subsidiaries and affiliates, whether now existing or hereafter established.

 

    	15

     

    

 

e.
Notices. All notices and other communications hereunder shall be in writing, and shall be deemed to have been duly
given if delivered personally or if sent by overnight courier or by certified mail, return receipt requested, postage prepaid,
to the relevant address set forth below, or to such other address as the recipient of such notice or communication shall have
specified in writing to the other Party hereto, in accordance with this Section 14(e).

 

	 	i.
    If to the Company: 	 	Surna
    Inc.
	 	 	 	1780
    55th Street, Suite A
	 	 	 	Boulder,
    Colorado 80301
	 	 	 	Attention:
    CEO

 

ii.
If to the Executive, at the Executive’s last residence shown on the records of the Company.

 

f.
Public Announcements. The Company intends to publicly announce and disclose this Agreement and the subject matter
hereof in accordance with applicable laws. Until such time as the Company has publicly announced and/or disclosed this Agreement
and the subject matter hereof, the Executive shall not publicly announce or disclose to any third party the existence of this
Agreement or the subject matter hereof.

 

g.
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be governed by and construed and enforced in accordance with the internal laws of the State of Colorado, without regard
to the principles of conflicts of law thereof.

 

h.
Equitable Relief. The Executive acknowledges and agrees that, notwithstanding anything herein to the contrary, including
without limitation Section 13(d) hereof, upon any breach by the Executive of the Executive’s obligations under Section 11,
the Company will have no adequate remedy at law, and accordingly shall be immediately entitled to specific performance and other
appropriate injunctive and equitable relief in a court of competent jurisdiction.

 

i.
Cooperation in Future Matters. The Executive hereby agrees that for a period of eighteen (18) months following the
Executive’s termination of employment, the Executive shall cooperate fully with the Company’s reasonable requests
relating to matters that pertain to the Executive’s employment by the Company, including, without limitation, providing
information or limited consultation as to such matters, participating in legal proceedings, investigations or audits on behalf
of the Company, or otherwise making himself reasonably available to the Company for other related purposes. Any such cooperation
shall be performed at scheduled times taking into consideration the Executive’s other commitments. The Executive shall not
be required to perform such cooperation to the extent it conflicts with any requirements of exclusivity of services for another
employer or otherwise, nor in any manner that in the good faith belief of the Executive would conflict with the Executive’s
rights under or ability to enforce this Agreement.

 

j.
Withholding. Any payments provided for in this Agreement shall be paid net of any applicable income tax withholding
required under federal, state or local law.

 

k.
Survival. Notwithstanding anything in this Agreement or elsewhere to the contrary, the provisions of Sections 9,
10, 11, 12, 13 and 14 shall survive the termination of the Executive’s employment or this Agreement.

 

l.
Execution and Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile,
electronic mail (including pdf or any electronic signature complying with the U.S. ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid
and effective for all purposes.

 

[Remainder
of this page intentionally left blank. Signature page follows.]

 

    	16

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year written below.

 

	EXECUTIVE	 	COMPANY 
		 	 	 
		 	Surna Inc.  
		 	 	 
	/s/
    Chris Bechtel	 	By:	/s/ Timothy
    J. Keating
	Chris
    Bechtel, Individually 	 	 	Timothy
    J. Keating, Chairman of the Board  

 

[Signature
Page to Executive Employment Agreement]

 

    	 	 	 

     

    

 

EXHIBIT
A

 

Permitted
Activities

 

Bechtel
Consulting, LLC – during the Term, the Executive will not engage in or provide any consulting services either individually
or through Bechtel Consulting, LLC without the prior approval of the Board.

 

Ravencrest
Resources, Inc. (CSE: RVT) – during the Term, the Executive may act as an independent director of Ravencrest Resources,
provided that the Board may require the Executive to resign from such director position if such position creates a conflict of
interest with the Company or requires more than ten (10) hours per month.

 

    	 	 	 

     

    

 

EXHIBIT
B

 

Form
of Restricted Stock Unit Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]